Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma
Research Grant
Awarded By
Karyopharm Therapeutics
Start Date
March 1, 2023
End Date
December 31, 2025
Awarded By
Karyopharm Therapeutics
Start Date
March 1, 2023
End Date
December 31, 2025